Company Filing History:

10 out of 94

A. Nattermann & Cie Gmbh

patents

5 out of 32

Troponwerke Gmbh & Co Kg

patents

2 out of 12,157

Bayer Aktiengesellschaft

patents

4. 2 out of 5

Nattermann & Cie Gmbh

patents

Years Active: 1981-1989

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4873350 - Diselenobis-benzoic acid amides of primary and secondary amines and (1989-10-10),

2. 4774252 - Benzisoselenazolonyl derivatives and processes for the treatment of (1988-09-27),

3. 4711961 - Benzisoselenazolethiones and process for the treatment of various (1987-12-08),

4. 4647560 - New benzodiazepines and their use (1987-03-03),

5. 4576626 - Foliage fertilizers (1986-03-18),

6. 4550168 - Benzisoselenazolones and a process for the treatment of inflammatory (1985-10-29),

7. 4505854 - Optically active dipeptides and the use thereof as tissue dissolving and (1985-03-19),

8. 4454068 - Cycloalkyl derivatives of benzisoselenazolones (1984-06-12),

9. 4397858 - Treatment of rheumatism and arteriosclerosis with (1983-08-09),

10. 4352799 - 2-Phenyl-1,2-benzisoselenazol-3(2H)-one containing pharmaceutical (1982-10-05),

11. 4349543 - Histolytic agents and their use (1982-09-14),

12. 4332819 - Antiphlogistic agent and its use (1982-06-01),

13. 4329361 - Use of rosmarinic acid in the treatment of inflammations and (1982-05-11),

14. 4310517 - Tumor-resolving and histolytic medicaments and their use (1982-01-12),

15. 4309421 - Stabilized parenterally administrable solutions (1982-01-05),

Title: **Eugen Etschenberg: A Pioneer in Chemical Innovations**

Introduction

Eugen Etschenberg, a distinguished inventor based in Cologne, Germany, has made significant contributions to the field of chemistry through his innovative inventions. With a remarkable portfolio of 19 patents, Etschenberg's work focuses on the development of novel compounds aimed at addressing various health issues.

Latest Patents

Etschenberg's latest patents include:

1. **Diselenobis-benzoic acid amides of primary and secondary amines**: This patent introduces new diselenobis-benzoic acid amides and details processes for the treatment of diseases in humans caused by cell injury.

2. **Benzisoselenazolonyl derivatives**: His work on benzisoselenazolonyl derivatives presents new compounds and processes for treating rheumatic diseases.

Career Highlights

Throughout his career, Etschenberg has been affiliated with notable companies such as A. Nattermann & Cie GmbH and Troponwerke GmbH & Co. KG. His innovative spirit and expertise in chemical research have helped propel the development of new therapeutic agents.

Collaborations

Eugen has collaborated with several accomplished professionals in the field, including Andre Welter and Wolfgang Opitz. Their collective efforts have fostered a rich environment for innovation and invention.

Conclusion

Eugen Etschenberg stands out as a prolific inventor whose contributions to chemical innovation are noteworthy. His dedication to advancing scientific knowledge and creating solutions for complex health issues reflect his commitment to improving human well-being. With a growing number of patents and collaborations, Etschenberg continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.